
Becton, Dickinson and Co.
BDXBecton, Dickinson and Co. (BDX) is a global medical technology company specializing in the development and manufacturing of medical devices, supplies, and laboratory equipment. Founded in 1897, it is known for its innovations in healthcare including syringes, safety-engineered devices, and diagnostic products, serving healthcare institutions, life sciences, and general medical markets worldwide.
Dividend History
Investors can expect a dividend payout of $1.05 per share, scheduled to be distributed in 23 days on December 31, 2025
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| December 31, 2025 | $1.05 | 2025-12-08 | 2025-12-08 |
| September 30, 2025 | $1.04 | 2025-09-08 | 2025-09-08 |
| June 30, 2025 | $1.04 | 2025-06-09 | 2025-06-09 |
| March 31, 2025 | $1.04 | 2025-03-10 | 2025-03-10 |
| December 31, 2024 | $1.04 | 2024-12-09 | 2024-12-09 |
Dividends Summary
- Becton, Dickinson and Co. has issued 89 dividend payments over the past 21 years
- The most recent dividend was paid 69 days ago, on September 30, 2025
- The highest dividend payed out to investors during this period was $1.05 per share
- The average dividend paid during this period was $0.58 per share.
Company News
The European market for glass prefilled syringes and glass vials packaging equipment is projected to grow from USD 283.30 billion in 2025 to USD 389.13 billion by 2034, driven by rising demand for injectable biologics, sterile drug delivery systems, and advanced healthcare infrastructure.
With market valuations high and potential corrections likely, the article recommends eight defensive dividend stocks across consumer staples, healthcare, and utility sectors that have consistently increased dividends for over 50 years.
Becton Dickinson announced CFO Chris DelOrefice will depart in December, with Vitor Roque named interim CFO. The company reported Q4 preliminary revenue of $5.9 billion and fiscal 2025 sales of $21.8 billion, slightly below consensus expectations.
The Cooper Companies is well-positioned for growth, driven by strong prospects in its CooperVision and CooperSurgical business segments. However, unfavorable currency movements and rising costs continue to impact revenues and margins.
Dividend aristocrats like Becton, Dickinson and Polaris are trading at 52-week lows. Read why these stocks present potentially attractive buying opportunities.







